Combining KHDC4 and TRAF2 with these downstream effectors as a signature also showed a positive correlation to E2F4 in TCGA-PRAD datasets (Spearman’s correlation = 0.43, p = 3.6E-23). Here, E2F4 is linked to prostate adenocarcinoma.